Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Not yet recruiting · NCT05411237 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma | AIDS, AIDS-related Kaposi sarcoma, Blood-Borne Infections, DNA Virus Infections, Genital Diseases, HIV infectious disease, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, neoplasm, sarcoma, sexually transmitted disease, uterine carcinosarcoma, vascular cancer, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-01-23 | NCT05411237 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AIDS Malignancy Consortium | 11 |
| National Cancer Institute (NCI) | 3015 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||